Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Myeloid, Acute | 17 | 2024 | 3524 | 0.910 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2023 | 407 | 0.590 |
Why?
|
Principal Component Analysis | 4 | 2008 | 940 | 0.580 |
Why?
|
Gene Expression Regulation, Neoplastic | 15 | 2022 | 8432 | 0.570 |
Why?
|
Neuroblastoma | 5 | 2023 | 1226 | 0.490 |
Why?
|
DNA, Mitochondrial | 3 | 2008 | 817 | 0.480 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 5 | 2022 | 105 | 0.470 |
Why?
|
RNA-Binding Protein EWS | 6 | 2022 | 216 | 0.470 |
Why?
|
Bone Neoplasms | 6 | 2022 | 2530 | 0.430 |
Why?
|
Glycogen Synthase Kinase 3 | 4 | 2022 | 430 | 0.410 |
Why?
|
Xenograft Model Antitumor Assays | 13 | 2021 | 3556 | 0.360 |
Why?
|
Gene Expression Profiling | 13 | 2017 | 9445 | 0.360 |
Why?
|
Cyclin-Dependent Kinase 4 | 3 | 2018 | 539 | 0.340 |
Why?
|
Neoplasm Proteins | 6 | 2018 | 3706 | 0.320 |
Why?
|
Oncogene Proteins, Fusion | 7 | 2022 | 1581 | 0.300 |
Why?
|
Oligonucleotide Array Sequence Analysis | 7 | 2015 | 3921 | 0.280 |
Why?
|
Drug Resistance, Neoplasm | 7 | 2021 | 5173 | 0.270 |
Why?
|
Creatine Kinase | 2 | 2018 | 694 | 0.270 |
Why?
|
I-kappa B Kinase | 2 | 2018 | 252 | 0.260 |
Why?
|
Proto-Oncogene Proteins c-myc | 4 | 2020 | 988 | 0.250 |
Why?
|
Cell Line, Tumor | 20 | 2023 | 16692 | 0.250 |
Why?
|
Drug Synergism | 5 | 2019 | 1797 | 0.240 |
Why?
|
Lymphoma, Follicular | 2 | 2005 | 435 | 0.240 |
Why?
|
Folic Acid | 2 | 2021 | 1300 | 0.240 |
Why?
|
Sulfonamides | 3 | 2024 | 1940 | 0.230 |
Why?
|
Breast Neoplasms | 8 | 2014 | 20823 | 0.220 |
Why?
|
Longevity | 2 | 2008 | 1071 | 0.210 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2023 | 167 | 0.210 |
Why?
|
Cystine | 1 | 2022 | 95 | 0.210 |
Why?
|
Lymphoma, B-Cell | 2 | 2006 | 931 | 0.210 |
Why?
|
Phylogeny | 2 | 2008 | 2804 | 0.200 |
Why?
|
Gangliosides | 1 | 2022 | 137 | 0.200 |
Why?
|
Glycine Hydroxymethyltransferase | 1 | 2021 | 32 | 0.200 |
Why?
|
Enzyme Inhibitors | 3 | 2023 | 3799 | 0.190 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2023 | 648 | 0.190 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2007 | 719 | 0.190 |
Why?
|
Indazoles | 2 | 2019 | 290 | 0.190 |
Why?
|
Cluster Analysis | 4 | 2008 | 2715 | 0.190 |
Why?
|
Immunologic Memory | 3 | 2017 | 1348 | 0.180 |
Why?
|
Meta-Analysis as Topic | 1 | 2005 | 1343 | 0.180 |
Why?
|
U937 Cells | 5 | 2020 | 268 | 0.180 |
Why?
|
Protein Kinase Inhibitors | 8 | 2023 | 5535 | 0.170 |
Why?
|
Lymphocytes | 1 | 2007 | 2617 | 0.170 |
Why?
|
Aminopyridines | 3 | 2019 | 542 | 0.170 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 3 | 2006 | 1378 | 0.170 |
Why?
|
Gene Expression Regulation, Leukemic | 3 | 2019 | 651 | 0.170 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2020 | 284 | 0.170 |
Why?
|
Homeodomain Proteins | 3 | 2021 | 2418 | 0.170 |
Why?
|
Y-Box-Binding Protein 1 | 1 | 2018 | 40 | 0.170 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2019 | 120 | 0.170 |
Why?
|
Cell Proliferation | 13 | 2021 | 10484 | 0.170 |
Why?
|
Azepines | 2 | 2018 | 336 | 0.160 |
Why?
|
Signal Transduction | 14 | 2022 | 23406 | 0.160 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2018 | 323 | 0.160 |
Why?
|
Bepridil | 1 | 2018 | 12 | 0.160 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2022 | 670 | 0.150 |
Why?
|
HMGB Proteins | 1 | 2017 | 45 | 0.150 |
Why?
|
Yellow Fever Vaccine | 1 | 2017 | 37 | 0.150 |
Why?
|
Receptor, erbB-2 | 1 | 2007 | 2417 | 0.150 |
Why?
|
Phenylenediamines | 1 | 2018 | 90 | 0.150 |
Why?
|
Bone Marrow | 2 | 2019 | 2948 | 0.150 |
Why?
|
Integrin beta3 | 2 | 2017 | 122 | 0.150 |
Why?
|
Methenyltetrahydrofolate Cyclohydrolase | 1 | 2016 | 9 | 0.140 |
Why?
|
Glioblastoma | 2 | 2010 | 3481 | 0.140 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2017 | 4479 | 0.140 |
Why?
|
Cell Death | 2 | 2019 | 1707 | 0.140 |
Why?
|
Small Molecule Libraries | 2 | 2019 | 720 | 0.140 |
Why?
|
Receptor, IGF Type 1 | 1 | 2018 | 390 | 0.140 |
Why?
|
Proteomics | 4 | 2022 | 3638 | 0.140 |
Why?
|
Proto-Oncogenes | 1 | 2017 | 321 | 0.140 |
Why?
|
Molecular Targeted Therapy | 5 | 2020 | 2726 | 0.140 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2015 | 2943 | 0.140 |
Why?
|
Clone Cells | 1 | 2019 | 1692 | 0.130 |
Why?
|
Cell Cycle Proteins | 5 | 2021 | 3465 | 0.130 |
Why?
|
Humans | 71 | 2024 | 744376 | 0.130 |
Why?
|
Gene Amplification | 2 | 2017 | 1063 | 0.130 |
Why?
|
Mice | 23 | 2023 | 81202 | 0.130 |
Why?
|
Cell Differentiation | 5 | 2017 | 11486 | 0.130 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2015 | 2455 | 0.130 |
Why?
|
Triazoles | 2 | 2018 | 910 | 0.130 |
Why?
|
Epigenesis, Genetic | 3 | 2018 | 3647 | 0.130 |
Why?
|
Citric Acid Cycle | 1 | 2016 | 232 | 0.130 |
Why?
|
Receptor, Notch1 | 1 | 2018 | 502 | 0.130 |
Why?
|
Mice, Inbred NOD | 4 | 2021 | 1879 | 0.120 |
Why?
|
Animals | 31 | 2023 | 168770 | 0.120 |
Why?
|
Genomics | 3 | 2014 | 5717 | 0.120 |
Why?
|
Haplotypes | 4 | 2012 | 2779 | 0.120 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2017 | 345 | 0.120 |
Why?
|
Calcium Channel Blockers | 1 | 2018 | 692 | 0.120 |
Why?
|
Methotrexate | 1 | 2021 | 1728 | 0.120 |
Why?
|
Wnt Proteins | 1 | 2018 | 721 | 0.120 |
Why?
|
HMGN1 Protein | 1 | 2014 | 27 | 0.120 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2016 | 1213 | 0.120 |
Why?
|
Up-Regulation | 4 | 2017 | 4222 | 0.120 |
Why?
|
Lymphocytic choriomeningitis virus | 2 | 2013 | 168 | 0.120 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2018 | 671 | 0.120 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2015 | 2916 | 0.120 |
Why?
|
Neoplasms | 6 | 2020 | 21693 | 0.120 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2015 | 165 | 0.120 |
Why?
|
Chemokine CCL5 | 1 | 2014 | 209 | 0.120 |
Why?
|
Antigens, Nuclear | 1 | 2014 | 192 | 0.120 |
Why?
|
Proteome | 1 | 2004 | 1798 | 0.120 |
Why?
|
Genome, Human | 4 | 2018 | 4420 | 0.120 |
Why?
|
Cyclin D1 | 1 | 2015 | 463 | 0.110 |
Why?
|
High-Throughput Screening Assays | 2 | 2019 | 944 | 0.110 |
Why?
|
Chromosome Mapping | 2 | 2016 | 4740 | 0.110 |
Why?
|
RNA Interference | 4 | 2018 | 2891 | 0.110 |
Why?
|
Purines | 1 | 2016 | 594 | 0.110 |
Why?
|
Genomic Instability | 1 | 2017 | 695 | 0.110 |
Why?
|
Antineoplastic Agents | 5 | 2021 | 13695 | 0.110 |
Why?
|
Gene Duplication | 1 | 2014 | 329 | 0.110 |
Why?
|
Lactase | 1 | 2012 | 69 | 0.110 |
Why?
|
T-Lymphocytes | 5 | 2023 | 10183 | 0.100 |
Why?
|
Ribonucleoproteins | 1 | 2014 | 381 | 0.100 |
Why?
|
Transcription Factors | 3 | 2017 | 12209 | 0.100 |
Why?
|
RNA, Neoplasm | 1 | 2014 | 769 | 0.100 |
Why?
|
Embryo, Nonmammalian | 1 | 2015 | 895 | 0.100 |
Why?
|
Arenaviridae Infections | 1 | 2011 | 51 | 0.100 |
Why?
|
Pyrimidines | 3 | 2018 | 2943 | 0.100 |
Why?
|
Brain Neoplasms | 2 | 2010 | 8862 | 0.090 |
Why?
|
Genetic Markers | 2 | 2008 | 2634 | 0.090 |
Why?
|
Nuclear Proteins | 4 | 2022 | 5857 | 0.090 |
Why?
|
Apoptosis | 7 | 2024 | 9726 | 0.090 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2014 | 491 | 0.090 |
Why?
|
Mice, Nude | 4 | 2019 | 3689 | 0.090 |
Why?
|
HL-60 Cells | 3 | 2016 | 365 | 0.090 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2015 | 789 | 0.090 |
Why?
|
Hematopoiesis | 2 | 2019 | 2073 | 0.090 |
Why?
|
Lysine | 1 | 2014 | 1007 | 0.090 |
Why?
|
Neoplasm Invasiveness | 2 | 2007 | 3616 | 0.090 |
Why?
|
Vital Capacity | 1 | 2012 | 925 | 0.090 |
Why?
|
Pan paniscus | 1 | 2008 | 5 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2018 | 2949 | 0.080 |
Why?
|
RNA, Messenger | 5 | 2015 | 13035 | 0.080 |
Why?
|
MicroRNAs | 3 | 2017 | 3751 | 0.080 |
Why?
|
Myelodysplastic Syndromes | 1 | 2019 | 1352 | 0.080 |
Why?
|
Myeloproliferative Disorders | 1 | 2015 | 606 | 0.080 |
Why?
|
Mutation | 10 | 2023 | 29786 | 0.080 |
Why?
|
Oncogene Proteins | 1 | 2013 | 749 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4464 | 0.080 |
Why?
|
Pan troglodytes | 1 | 2008 | 229 | 0.080 |
Why?
|
Benzamides | 3 | 2019 | 1379 | 0.080 |
Why?
|
Carrier Proteins | 1 | 2021 | 5023 | 0.080 |
Why?
|
Genes, erbB-1 | 1 | 2008 | 161 | 0.080 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2010 | 379 | 0.080 |
Why?
|
DNA Modification Methylases | 1 | 2008 | 206 | 0.080 |
Why?
|
Antigen Presentation | 1 | 2013 | 1284 | 0.080 |
Why?
|
Computer Simulation | 4 | 2017 | 6194 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9240 | 0.080 |
Why?
|
DNA Methylation | 4 | 2022 | 4287 | 0.080 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 1520 | 0.080 |
Why?
|
Databases, Nucleic Acid | 1 | 2008 | 211 | 0.080 |
Why?
|
Drug Discovery | 1 | 2015 | 1058 | 0.070 |
Why?
|
Gene Dosage | 2 | 2010 | 1252 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 2110 | 0.070 |
Why?
|
Exercise Tolerance | 1 | 2012 | 768 | 0.070 |
Why?
|
Neurofibromin 1 | 1 | 2008 | 196 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2004 | 4839 | 0.070 |
Why?
|
Cell Survival | 4 | 2021 | 5882 | 0.070 |
Why?
|
Carcinoma, Ductal | 1 | 2007 | 101 | 0.070 |
Why?
|
Zebrafish | 4 | 2021 | 2996 | 0.070 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1596 | 0.070 |
Why?
|
Transforming Growth Factor beta | 2 | 2019 | 2007 | 0.070 |
Why?
|
DNA Repair Enzymes | 1 | 2008 | 349 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2016 | 15520 | 0.070 |
Why?
|
Genes, erbB-2 | 1 | 2007 | 162 | 0.070 |
Why?
|
RNA, Small Interfering | 4 | 2018 | 3505 | 0.070 |
Why?
|
Japan | 2 | 2008 | 1360 | 0.070 |
Why?
|
Dipeptides | 2 | 2018 | 409 | 0.070 |
Why?
|
DNA Repair | 2 | 2021 | 2046 | 0.070 |
Why?
|
Phosphorylation | 4 | 2019 | 8437 | 0.070 |
Why?
|
Emigration and Immigration | 1 | 2008 | 402 | 0.070 |
Why?
|
Logic | 1 | 2005 | 39 | 0.070 |
Why?
|
Diet, Gluten-Free | 1 | 2008 | 271 | 0.070 |
Why?
|
Protein Structure, Tertiary | 2 | 2013 | 3848 | 0.070 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2019 | 1723 | 0.070 |
Why?
|
Receptors, Immunologic | 1 | 2011 | 1423 | 0.060 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2005 | 129 | 0.060 |
Why?
|
Carcinoma, Renal Cell | 2 | 2010 | 3143 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2014 | 3203 | 0.060 |
Why?
|
Discriminant Analysis | 1 | 2005 | 235 | 0.060 |
Why?
|
Promoter Regions, Genetic | 4 | 2021 | 5868 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2018 | 2938 | 0.060 |
Why?
|
Neurofibromatosis 1 | 1 | 2010 | 570 | 0.060 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2021 | 640 | 0.060 |
Why?
|
Female | 21 | 2021 | 380200 | 0.060 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2010 | 871 | 0.060 |
Why?
|
Multigene Family | 1 | 2007 | 1102 | 0.060 |
Why?
|
Down-Regulation | 3 | 2018 | 3001 | 0.060 |
Why?
|
Computational Biology | 2 | 2007 | 3519 | 0.060 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 504 | 0.060 |
Why?
|
Cells | 1 | 2005 | 168 | 0.060 |
Why?
|
Genes, Tumor Suppressor | 1 | 2008 | 1097 | 0.060 |
Why?
|
Histones | 1 | 2014 | 2599 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2006 | 381 | 0.060 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2006 | 415 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 2 | 2018 | 1632 | 0.060 |
Why?
|
Mice, SCID | 2 | 2021 | 2717 | 0.060 |
Why?
|
Cyclin-Dependent Kinase 8 | 1 | 2023 | 52 | 0.060 |
Why?
|
Kidney Neoplasms | 2 | 2010 | 4262 | 0.060 |
Why?
|
T-Lymphocyte Subsets | 1 | 2011 | 1837 | 0.060 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2024 | 195 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3596 | 0.060 |
Why?
|
Mice, Inbred C57BL | 6 | 2020 | 21833 | 0.060 |
Why?
|
Prognosis | 6 | 2021 | 29060 | 0.050 |
Why?
|
Dendritic Cells | 1 | 2013 | 2725 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2021 | 6314 | 0.050 |
Why?
|
Daunorubicin | 1 | 2022 | 158 | 0.050 |
Why?
|
Sulfasalazine | 1 | 2022 | 79 | 0.050 |
Why?
|
Pattern Recognition, Automated | 2 | 2007 | 1005 | 0.050 |
Why?
|
Disease Progression | 3 | 2007 | 13285 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11525 | 0.050 |
Why?
|
Databases as Topic | 1 | 2004 | 475 | 0.050 |
Why?
|
Sequence Alignment | 1 | 2006 | 2256 | 0.050 |
Why?
|
Prostatic Hyperplasia | 1 | 2006 | 523 | 0.050 |
Why?
|
POU Domain Factors | 1 | 2021 | 46 | 0.050 |
Why?
|
DNA Mutational Analysis | 2 | 2010 | 4185 | 0.050 |
Why?
|
Animals, Genetically Modified | 2 | 2017 | 1549 | 0.050 |
Why?
|
Calibration | 1 | 2004 | 816 | 0.050 |
Why?
|
MAP Kinase Signaling System | 2 | 2019 | 1525 | 0.050 |
Why?
|
Linkage Disequilibrium | 1 | 2006 | 1997 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2015 | 15078 | 0.050 |
Why?
|
Histocompatibility Antigens | 1 | 2022 | 471 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 4751 | 0.050 |
Why?
|
Laboratories | 1 | 2005 | 463 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2021 | 4208 | 0.050 |
Why?
|
Models, Biological | 3 | 2010 | 9584 | 0.050 |
Why?
|
Nucleotides | 1 | 2023 | 464 | 0.050 |
Why?
|
Antigens, CD | 1 | 2011 | 4026 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4666 | 0.050 |
Why?
|
beta Catenin | 2 | 2018 | 1059 | 0.050 |
Why?
|
Databases, Genetic | 1 | 2007 | 1783 | 0.050 |
Why?
|
Neoplastic Stem Cells | 1 | 2008 | 1376 | 0.050 |
Why?
|
Biological Evolution | 1 | 2006 | 1077 | 0.050 |
Why?
|
Genome-Wide Association Study | 2 | 2017 | 12262 | 0.050 |
Why?
|
NF-kappa B | 2 | 2022 | 2499 | 0.050 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 4805 | 0.050 |
Why?
|
Celiac Disease | 1 | 2008 | 785 | 0.050 |
Why?
|
Diphenylamine | 1 | 2019 | 50 | 0.040 |
Why?
|
Adoptive Transfer | 2 | 2013 | 844 | 0.040 |
Why?
|
Evolution, Molecular | 1 | 2008 | 1939 | 0.040 |
Why?
|
Genes, Neoplasm | 2 | 2016 | 376 | 0.040 |
Why?
|
Histone Demethylases | 1 | 2022 | 321 | 0.040 |
Why?
|
Protein Stability | 1 | 2021 | 556 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2017 | 9647 | 0.040 |
Why?
|
Ubiquitination | 1 | 2024 | 1012 | 0.040 |
Why?
|
Statistics as Topic | 1 | 2006 | 2373 | 0.040 |
Why?
|
Smad2 Protein | 1 | 2019 | 156 | 0.040 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 234 | 0.040 |
Why?
|
Receptors, Estrogen | 1 | 2007 | 2190 | 0.040 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2006 | 1100 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2020 | 6387 | 0.040 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2019 | 322 | 0.040 |
Why?
|
Radioisotope Dilution Technique | 1 | 2017 | 70 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 808 | 0.040 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2019 | 323 | 0.040 |
Why?
|
Yellow fever virus | 1 | 2017 | 22 | 0.040 |
Why?
|
Models, Molecular | 1 | 2008 | 5451 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 1 | 2008 | 2850 | 0.040 |
Why?
|
Deuterium | 1 | 2017 | 101 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2019 | 489 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2008 | 4328 | 0.040 |
Why?
|
Reproducibility of Results | 4 | 2018 | 19905 | 0.040 |
Why?
|
Polymers | 1 | 2005 | 1621 | 0.040 |
Why?
|
Blotting, Western | 2 | 2017 | 5181 | 0.040 |
Why?
|
Algorithms | 4 | 2007 | 13882 | 0.040 |
Why?
|
Patient Compliance | 1 | 2008 | 2685 | 0.040 |
Why?
|
Yellow Fever | 1 | 2017 | 53 | 0.040 |
Why?
|
Cysteine | 1 | 2022 | 873 | 0.040 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2005 | 1381 | 0.040 |
Why?
|
Aged, 80 and over | 4 | 2017 | 57776 | 0.040 |
Why?
|
Phenotype | 3 | 2015 | 16367 | 0.040 |
Why?
|
Karyotyping | 1 | 2019 | 1243 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2019 | 629 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2024 | 1434 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2020 | 14561 | 0.040 |
Why?
|
Adenosine Triphosphatases | 1 | 2021 | 839 | 0.040 |
Why?
|
Mitochondria | 2 | 2022 | 3514 | 0.040 |
Why?
|
Half-Life | 1 | 2017 | 661 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2004 | 2204 | 0.040 |
Why?
|
Biocompatible Materials | 1 | 2005 | 1736 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2019 | 811 | 0.030 |
Why?
|
Drug Resistance | 1 | 2022 | 1608 | 0.030 |
Why?
|
Transfection | 2 | 2015 | 5895 | 0.030 |
Why?
|
Peptides, Cyclic | 1 | 2018 | 400 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2007 | 14723 | 0.030 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2021 | 736 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2021 | 1152 | 0.030 |
Why?
|
Recurrence | 1 | 2007 | 8340 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2019 | 733 | 0.030 |
Why?
|
Decision Support Techniques | 1 | 2006 | 1956 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6539 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2017 | 793 | 0.030 |
Why?
|
Bone Marrow Examination | 1 | 2015 | 157 | 0.030 |
Why?
|
Models, Genetic | 1 | 2006 | 3493 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2018 | 730 | 0.030 |
Why?
|
Artificial Intelligence | 2 | 2007 | 2213 | 0.030 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2014 | 15 | 0.030 |
Why?
|
Chemotaxis | 1 | 2018 | 607 | 0.030 |
Why?
|
Sarcoma | 1 | 2006 | 1897 | 0.030 |
Why?
|
Genes, ras | 1 | 2017 | 690 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2021 | 1341 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2007 | 21747 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2019 | 1401 | 0.030 |
Why?
|
Base Sequence | 3 | 2013 | 12797 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 2 | 2019 | 3390 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2018 | 7722 | 0.030 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2014 | 230 | 0.030 |
Why?
|
Thiophenes | 1 | 2018 | 589 | 0.030 |
Why?
|
Pyrazines | 1 | 2019 | 1230 | 0.030 |
Why?
|
Aged | 7 | 2017 | 163284 | 0.030 |
Why?
|
Janus Kinases | 1 | 2014 | 244 | 0.030 |
Why?
|
Adult | 9 | 2023 | 214056 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2015 | 19233 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 5223 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2018 | 1730 | 0.030 |
Why?
|
Middle Aged | 8 | 2017 | 213388 | 0.030 |
Why?
|
rab3 GTP-Binding Proteins | 1 | 2012 | 29 | 0.030 |
Why?
|
Cell Cycle | 1 | 2021 | 2968 | 0.030 |
Why?
|
Male | 10 | 2020 | 350118 | 0.030 |
Why?
|
Quinazolines | 1 | 2019 | 1356 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2017 | 783 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2015 | 552 | 0.030 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2012 | 115 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2013 | 399 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2086 | 0.030 |
Why?
|
Child | 5 | 2022 | 77708 | 0.030 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2014 | 434 | 0.030 |
Why?
|
Technology, Pharmaceutical | 1 | 2012 | 84 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2004 | 3589 | 0.030 |
Why?
|
Peptides | 1 | 2004 | 4410 | 0.030 |
Why?
|
Transgenes | 1 | 2015 | 1009 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 1656 | 0.020 |
Why?
|
Trans-Activators | 1 | 2021 | 2926 | 0.020 |
Why?
|
Methylation | 1 | 2014 | 1106 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2015 | 1950 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 2012 | 383 | 0.020 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2012 | 300 | 0.020 |
Why?
|
Indoles | 1 | 2019 | 1839 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2014 | 1799 | 0.020 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2013 | 294 | 0.020 |
Why?
|
Nucleosomes | 1 | 2014 | 494 | 0.020 |
Why?
|
Models, Statistical | 1 | 2005 | 5101 | 0.020 |
Why?
|
Kenya | 1 | 2012 | 685 | 0.020 |
Why?
|
Paracrine Communication | 1 | 2011 | 278 | 0.020 |
Why?
|
Antigen-Presenting Cells | 1 | 2013 | 973 | 0.020 |
Why?
|
Semaphorins | 1 | 2010 | 101 | 0.020 |
Why?
|
Software | 1 | 2004 | 4442 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1915 | 0.020 |
Why?
|
Cell Line | 2 | 2019 | 16000 | 0.020 |
Why?
|
Dexamethasone | 1 | 2016 | 1951 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2015 | 3702 | 0.020 |
Why?
|
Fluorouracil | 1 | 2014 | 1619 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2014 | 1179 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2014 | 1758 | 0.020 |
Why?
|
Cell Movement | 1 | 2021 | 5218 | 0.020 |
Why?
|
Genome | 1 | 2017 | 1807 | 0.020 |
Why?
|
Zebrafish Proteins | 1 | 2015 | 1005 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6489 | 0.020 |
Why?
|
Time Factors | 2 | 2015 | 40077 | 0.020 |
Why?
|
Metabolomics | 1 | 2017 | 1485 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2018 | 6896 | 0.020 |
Why?
|
Tanzania | 1 | 2012 | 1346 | 0.020 |
Why?
|
Adolescent | 4 | 2008 | 85784 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2019 | 1736 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2012 | 1617 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2011 | 805 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2010 | 980 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2012 | 13104 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2010 | 977 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2013 | 18111 | 0.020 |
Why?
|
Culture Media, Conditioned | 1 | 2008 | 537 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4445 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2010 | 2050 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2014 | 2012 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 5974 | 0.020 |
Why?
|
Cell Communication | 1 | 2013 | 1621 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 950 | 0.020 |
Why?
|
Chromatin | 1 | 2017 | 2934 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2014 | 2765 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2010 | 2327 | 0.020 |
Why?
|
Viral Vaccines | 1 | 2011 | 636 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2018 | 3590 | 0.020 |
Why?
|
Gene Frequency | 1 | 2012 | 3587 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9274 | 0.020 |
Why?
|
Walking | 1 | 2012 | 1180 | 0.020 |
Why?
|
Software Design | 1 | 2005 | 176 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2005 | 191 | 0.020 |
Why?
|
Dyspnea | 1 | 2012 | 1303 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2012 | 1889 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2008 | 2505 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2012 | 77459 | 0.010 |
Why?
|
DNA Primers | 1 | 2008 | 2891 | 0.010 |
Why?
|
Proteins | 1 | 2018 | 6100 | 0.010 |
Why?
|
Cholesterol | 1 | 2012 | 2919 | 0.010 |
Why?
|
Program Evaluation | 1 | 2012 | 2488 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10943 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2006 | 11126 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10636 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2013 | 5524 | 0.010 |
Why?
|
Viral Load | 1 | 2011 | 3300 | 0.010 |
Why?
|
Genes, p53 | 1 | 2005 | 755 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2012 | 15535 | 0.010 |
Why?
|
Reference Standards | 1 | 2006 | 1025 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2013 | 3475 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11366 | 0.010 |
Why?
|
Acute Disease | 1 | 2011 | 7147 | 0.010 |
Why?
|
Patient Care Team | 1 | 2012 | 2531 | 0.010 |
Why?
|
Molecular Structure | 1 | 2005 | 1899 | 0.010 |
Why?
|
Cell Division | 1 | 2008 | 4569 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2006 | 12961 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12788 | 0.010 |
Why?
|
Clinical Laboratory Techniques | 1 | 2005 | 738 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 9735 | 0.010 |
Why?
|
Data Collection | 1 | 2008 | 3339 | 0.010 |
Why?
|
Neurons | 1 | 2017 | 9340 | 0.010 |
Why?
|
Fibroblasts | 1 | 2008 | 4162 | 0.010 |
Why?
|
Protein Kinases | 1 | 2005 | 1640 | 0.010 |
Why?
|
Comorbidity | 1 | 2012 | 10388 | 0.010 |
Why?
|
Prostate | 1 | 2006 | 1775 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2012 | 3047 | 0.010 |
Why?
|
Gene Expression | 1 | 2010 | 7798 | 0.010 |
Why?
|
Cytokines | 1 | 2011 | 7323 | 0.010 |
Why?
|
Chronic Disease | 1 | 2011 | 9145 | 0.010 |
Why?
|
Risk Factors | 2 | 2015 | 72295 | 0.010 |
Why?
|
Alleles | 1 | 2006 | 6933 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17445 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2012 | 63115 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2005 | 4554 | 0.010 |
Why?
|
Databases, Factual | 1 | 2005 | 7730 | 0.010 |
Why?
|
Age Factors | 1 | 2006 | 18373 | 0.010 |
Why?
|
Rats | 1 | 2005 | 24252 | 0.010 |
Why?
|
Cohort Studies | 1 | 2010 | 40558 | 0.000 |
Why?
|
Quality of Life | 1 | 2008 | 12803 | 0.000 |
Why?
|
Child, Preschool | 1 | 2008 | 41005 | 0.000 |
Why?
|